Onesource Company Profile

« Back to Dashboard

What is the competitive landscape for ONESOURCE

ONESOURCE has forty-six approved drugs.

Summary for Onesource

US Patents:	0
Tradenames:	41
Ingredients:	37
NDAs:	46

Drugs and US Patents for Onesource

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Onesource Specialty	NAFCILLIN SODIUM	nafcillin sodium	INJECTABLE;INJECTION	200002-002	Apr 7, 2014	AP	RX	No	No
Onesource Specialty	AMPICILLIN AND SULBACTAM	ampicillin sodium; sulbactam sodium	INJECTABLE;INJECTION	201024-002	Apr 7, 2014	AP	RX	No	No
Onesource Specialty	BENZONATATE	benzonatate	CAPSULE;ORAL	091133-001	Jul 30, 2015	AA	RX	No	No
Onesource Specialty	METOPROLOL TARTRATE	metoprolol tartrate	INJECTABLE;INJECTION	090317-001	Apr 19, 2010		DISCN	No	No
Onesource	DUTASTERIDE	dutasteride	CAPSULE;ORAL	204262-001	Nov 20, 2015	AB	RX	No	No
Onesource	NAPROXEN SODIUM	naproxen sodium	CAPSULE;ORAL	215472-001	Aug 17, 2022		DISCN	No	No

Expired US Patents for Onesource

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Onesource Specialty	VEPESID	etoposide	CAPSULE;ORAL	019557-001	Dec 30, 1986	3,524,844
Onesource Specialty	VEPESID	etoposide	CAPSULE;ORAL	019557-002	Dec 30, 1986	3,524,844

Paragraph IV (Patent) Challenges for ONESOURCE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	for Injection	100 mcg/vial and 500 mcg/vial		2015-04-14
	for Injection	200 mcg/vial		2015-05-01

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Onesource
• Onesource Specialty